reviews of glp-1 weight loss is driven mainly by fat loss, not muscle loss Those discontinuing GLP-1 medications rapidly

This is because hair follicles also have a resting phase lasting between 3 and 4 months

In recent years, EAT has garnered extensive attention as a key risk factor for cardiovascular disease and a potential therapeutic target

It does not appear on the list of controlled substances, but its sale as a dietary supplement or health product is not authorized

In Phase 3 trials, retatrutide helped patients with Type 2 diabetes lose up to 16.8% of their body weight over 40 weeks, while also significantly improving blood sugar levels

Some of the popular brands include Ozempic, Mounjaro, Wegovy and Zepbound

Cardiovascular outcome trials for tirzepatide are ongoing, but the favorable effects on intermediate markers suggest probable long-term cardiovascular benefit